N-Acetylcarnosine
A carnosine derivative sold as eye drops claimed to dissolve cataracts. A Cochrane review found no trial evidence good enough to support the claim, and the positive studies all trace back to a single research group.
Evidence last reviewed: August 2026
What the science says
- Reversing or slowing cataract Limited evidence
A Cochrane systematic review on N-acetylcarnosine drops for age-related cataract found no adequately reported randomised trials meeting inclusion criteria and concluded there is no convincing evidence of benefit. The frequently cited positive results come from one group and were not independently replicated.
- Antioxidant protection of the lens Limited evidence
A narrative review of carnosine and beta-alanine in human medicine describes carnosine's antiglycation and antioxidant properties as biologically plausible for lens proteins, while noting that clinical translation to eye disease has not been demonstrated. Mechanism is not the same as outcome.
- Alternative to cataract surgery Limited evidence
No trial has compared N-acetylcarnosine drops against cataract surgery or shown that they prevent the need for it. Cataract surgery remains the only intervention with established efficacy.
Dosage & safety
Scientific references
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Eye health
- Lutein & Zeaxanthin Moderate evidence
- Goji Berry Limited evidence
- Bilberry Limited evidence
- AREDS2 Eye Formula Strong evidence
- Eyebright Limited evidence
- Meso-Zeaxanthin Moderate evidence